Aemetis reported bad earnings, which is reason enough to sell the stock. x.com 

Aemetis is undervalued at a ~$200M market cap as layered tax credits and operational catalysts across biofuels, renewable natural gas and carbon capture drive it toward imminent profitability. A projected $400M of 45Z tax credit revenue through 2029, with upside if credits are extended, underpins margin expansion, and liquidity from its India IPO could unlock value. The stock trades above its 50- and 200-day moving averages. It suits risk-tolerant growth investors. x.com  x.com